Home    Back

18. Spinocerebellar degeneration
59 clinical trials,   78 drugs   (DrugBank: 28 drugs),   44 drug target genes,   59 drug target pathways

Searched query = "Spinocerebellar degeneration", "SCD", "Spinocerebellar ataxia type I", "SCA1", "Spinocerebellar ataxia type II", "SCA2", "Spinocerebellar ataxia type III", "SCA3", "Machado-Joseph disease", "Spinocerebellar ataxia type VI", "SCA6", "Spinocerebellar ataxia type VII", "SCA7", "Spinocerebellar ataxia type X", "SCA10", "Spinocerebellar ataxia type XII", "SCA12", "Dentatorubural pallidoluysian atrophy", "Dentatorubropallidoluysial atrophy", "DRPLA", "Naito-Koyanagi disease", "Friedreich ataxia", "FRDA", "Ataxia with vitamin E deficiency", "AVED", "Early-onset ataxia with ocular motor ataxia and hypoalbuminemia", "EOAH"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03933163
(ClinicalTrials.gov)		May 23, 201916/4/2019Micronised Resveratrol as a Treatment for Friedreich AtaxiaA Randomised Placebo-controlled Crossover Trial of Micronised Resveratrol as a Treatment for Friedreich AtaxiaFriedreich AtaxiaDrug: ResveratrolMurdoch Childrens Research InstituteNULLRecruiting16 YearsN/AAll40Phase 2Australia
2NCT01339884
(ClinicalTrials.gov)		April 201114/4/2011A Study of Resveratrol as Treatment for Friedreich AtaxiaAn Open Label Clinical Pilot Study of Resveratrol as Treatment for Friedreich AtaxiaFriedreich AtaxiaDrug: ResveratrolMurdoch Childrens Research InstituteFriedreich's Ataxia Research AllianceCompleted18 YearsN/ABoth27Phase 1;Phase 2Australia